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The origins of current understanding of hemodynamics and of their echo-cardiography-based assessment are cardiac catheterization diagnostic tech-niques. Cardiac catheterization was essential for hemodynamic assessment 
and diagnosis in the 1950s and 1960s, and it was the gold standard for the vali-
dation of Doppler echocardiography developments in the 1980s and 1990s.1 Fur-
thermore, the assessment of hemodynamics during exertion began with cardiac 
catheterization2 only to evolve substantially with echocardiography because of the 
noninvasive nature of this modality, making it more practical and easy to repeat at 
follow-up. The study of Utsunomiya et al3 represents a return back to the origins, 
revalidating echocardiographic measures of pulmonary pressure and cardiac out-
put during exercise with simultaneous cardiac catheterization and echocardiogra-
phy in patients with degenerative mitral regurgitation. Echocardiography remains 
the first-line tool for the assessment of pulmonary artery pressure; however, cur-
rent guidelines4 lead to a return back to the origins, recognizing the limitations 
of echocardiography and, consequently, increasing the role of right heart cardiac 
catheterization at rest. Nevertheless, during exertion, Utsunomiya et al3 found good 
agreement between echocardiographic and invasive measures of pulmonary artery 
pressure, of cardiac output, of pulmonary vascular resistance, and right ventricular 
contractile reserve, revalidating the use of supine bicycle stress echocardiography 
in primary mitral regurgitation. The aim of their study was not to validate exercise 
echocardiography but to define the mechanisms of exercise intolerance in hemo-
dynamically significant primary mitral regurgitation.
Exercise intolerance and exertional symptoms represent a class I indication for 
intervention in patients with severe primary mitral regurgitation5–7 and can be 
unmasked in asymptomatic patients with exercise testing alone or when combined 
with echocardiography.8,9 Echocardiography adds the benefit of concomitant assess-
ment of mitral regurgitation,10,11 left ventricular and right ventricular functional 
reserve,12,13 and pulmonary pressure14,15 responses during exercise. An increase in the 
severity of mitral regurgitation,11 lack of contractile reserve,16 and systolic pulmonary 
arterial pressure rise to >60 mm Hg,14 as well as exercise-induced right ventricular 
systolic dysfunction,15 were found to have predictive value for the development of 
symptoms or other indications for intervention. Utsunomiya et al3 focused on identi-
fying parameters that correlate with exercise intolerance rather than predict it. They 
found exercise intolerance to correlate not only with dynamic mitral regurgitation 
and pulmonary hypertension but also with chronotropic incompetence, pulmonary 
vascular reserve (mean pulmonary artery pressure to cardiac output ratio slope), and 
right ventricular contractile reserve (tricuspid annulus plane systolic excursion to sys-
tolic pulmonary artery pressure ratio slope; Figure). Overall, the level of increase in 
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pulmonary artery pressure depends on the right ventricu-
lar function, the ability to successfully recruit the pulmo-
nary vasculature to accommodate the increased blood 
flow with exercise, the contribution (or proportion) of 
the reduction in the cross-sectional area of the pulmo-
nary circulation, the changes in pulmonary vascular com-
pliance, resistance and impedance, and the increase in 
left atrial pressure. In practice, parameters of pulmonary 
vascular reserve and right ventricular contractile function 
are relatively easy to calculate and add to a valve stress 
echo protocol in primary mitral regurgitation. Neverthe-
less, further evidence from a larger study of asymptom-
atic patients with severe mitral regurgitation is needed, 
before recommending routine use of these parameters 
in clinical practice.
An important contribution of this study is the addition 
of cardiopulmonary exercise testing to hemodynamic 
assessment, providing the benefit of an objective mea-
sure of exercise tolerance: the peak oxygen consumption 
(VO2).
17 The addition of cardiac catheterization to echo-
cardiography during exercise testing is impractical and 
demonstrated by this study to be unnecessary as well. 
However, cardiopulmonary exercise testing can be eas-
ily combined with echocardiography. Cardiopulmonary 
exercise testing was introduced in clinical practice18 well 
before exercise echocardiography and using it to deter-
mine exercise tolerance represents as well a return back 
to the origins of diagnostic assessment. The detection 
of symptoms or exercise intolerance can be challeng-
ing not only in sedentary patients but also in patients 
used to physical exercise, who are less likely to complain 
of symptoms during usual daily activities. Admitting to 
symptoms depends on personality, mood, culture, idio-
syncrasy, cognition, literacy, and socioeconomics.17 The 
need for objective measures of exercise tolerance to 
inform the timing of intervention is particularly well rec-
ognized in degenerative mitral regurgitation, predomi-
nantly in young patients with valve morphology suitable 
for successful durable repair, likely to benefit from early 
mitral valve surgery.5–7 Exercise tolerance depends on the 
ability of the cardiovascular system to increase oxygen 
supply during exertion, according to the increase in oxy-
gen consumption, by increasing cardiac output; there-
fore, the peak oxygen consumption corresponds to the 
maximal exercise tolerance.17 Cardiopulmonary exercise 
testing has been used for a wide range of applications, 
from determining the exercise tolerance of trained ath-
letes to the assessment of heart failure patients. Return-
ing back to the origins of physiological assessment, 
cardiopulmonary exercise testing may begin to play an 
important role in the timing of intervention in asymp-
tomatic patients with valvular heart disease.
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